Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

)A Study to Evaluate the Erythropoietic Response in HCV/HIV Co-Infected Patients Receiving Combination Ribavirin/Interferon Therapy

NCT00315432 is registered in ClinicalTrials.gov with Ortho Biotech Products, L.P. as lead sponsor.

NCT NCT00315432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00315432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
)A Study to Evaluate the Erythropoietic Response in HCV/HIV Co-Infected Patients Receiving Combination Ribavirin/Interferon Therapy
Lead sponsor
Ortho Biotech Products, L.P.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2000
Completion date
November 30, 2003
Enrollment
91 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, hepatitis c, hiv